Literature DB >> 11128657

CTLA-4 gene polymorphism in Japanese patients with rheumatoid arthritis.

T Yanagawa1, K Gomi, E I Nakao, S Inada.   

Abstract

OBJECTIVE: To examine whether CTLA-4 gene confers susceptibility to rheumatoid arthritis (RA) in Japanese.
METHODS: We investigated the distribution of a CTLA-4 gene polymorphism in 85 Japanese patients with RA and 200 controls. An A/G transition at position 49 of exon 1 was analyzed by the polymerase chain reaction (PCR)-restriction fragment length polymorphism method. The patients were also analyzed with respect to HLA-DR status. HLA-DR typing was performed by PCR sequence-specific oligonucleotide typing.
RESULTS: The distribution of genotype frequencies differed between RA and controls (chi-squared 8.63, 2 df, p = 0.013). The CTLA-4 AG genotype occurred more frequently in patients with RA (59 vs 44%), and the presence of at least one G allele (GG or AG) conferred an odds ratio of 2.53 (95% CI 1.74-3.32). When the patients were analyzed with respect to HLA-DR status, this association was restricted to patients carrying the susceptible HLA allele (HLA-DRB1*0405).
CONCLUSION: The CTLA-4 gene is associated with Japanese patients with RA carrying the susceptible HLA allele.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128657

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  CTLA-4 gene polymorphism in promoter and exon-1 regions is not associated with Chinese patients with rheumatoid arthritis.

Authors:  Ming-Fei Liu; Chrong-Reen Wang; Pei-Chih Chen; Tsung-Liang Lin
Journal:  Clin Rheumatol       Date:  2004-01-28       Impact factor: 2.980

2.  Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis.

Authors:  Xiaobo Li; Cong Zhang; Jie Zhang; Yonggang Zhang; Zhangjun Wu; Lian Yang; Zhangpeng Xiang; Zhanzhong Qi; Xin Zhang; Xingqiong Xiao
Journal:  J Clin Immunol       Date:  2012-02-23       Impact factor: 8.317

3.  Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis.

Authors:  Shizhong Han; Yao Li; Yumin Mao; Yi Xie
Journal:  Hum Genet       Date:  2005-08-17       Impact factor: 4.132

Review 4.  CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis-results and the review of the literature.

Authors:  Karim Benhatchi; Ivana Jochmanová; Viera Habalová; Hedviga Wagnerová; Ivica Lazúrová
Journal:  Clin Rheumatol       Date:  2011-04-19       Impact factor: 2.980

5.  CTLA4 is differentially associated with autoimmune diseases in the Dutch population.

Authors:  Alexandra Zhernakova; Peter Eerligh; Pilar Barrera; Joanna Z Wesoly; Joanna Z Weseloy; Tom W J Huizinga; Bart O Roep; Cisca Wijmenga; Bobby P C Koeleman
Journal:  Hum Genet       Date:  2005-07-16       Impact factor: 4.132

6.  Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2011-12-18       Impact factor: 2.316

7.  Cytotoxic T lymphocyte-Associated Antigen +49G Variant Confers Risk for Anti-CCP- and Rheumatoid Factor-Positive Type of Rheumatoid Arthritis Only in Combination with CT60G Allele.

Authors:  Bernadett Farago; Peter Kisfali; Lili Magyari; Noemi Polgar; Bela Melegh
Journal:  Autoimmune Dis       Date:  2009-08-27

8.  Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity.

Authors:  Suad AlFadhli
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-28

9.  Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto's thyroiditis in Japanese population.

Authors:  M Terauchi; T Yanagawa; N Ishikawa; K Ito; T Fukazawa; H Maruyama; T Saruta
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

10.  Association of the CTLA-4 +49A/G polymorphism with rheumatoid arthritis in Chinese Han population.

Authors:  Ming-Jie Tang; Zu-Bin Zhou
Journal:  Mol Biol Rep       Date:  2012-12-20       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.